Pear Therapeutics, Inc.
PEAR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$75 | -$65 | -$97 | -$9 |
| Dep. & Amort. | $6 | $2 | $0 | $0 |
| Deferred Tax | $0 | $0 | $2 | -$20 |
| Stock-Based Comp. | $14 | $4 | $9 | $1 |
| Change in WC | -$10 | -$6 | $1 | -$7 |
| Other Non-Cash | -$48 | -$44 | $17 | -$1 |
| Operating Cash Flow | -$114 | -$109 | -$68 | -$37 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$5 | -$4 | -$0 |
| Net Acquisitions | $0 | -$1 | $0 | $0 |
| Inv. Purchases | -$66 | -$8 | -$16 | -$195 |
| Inv. Sales/Matur. | $60 | $17 | $80 | $155 |
| Other Inv. Act. | $0 | $0 | -$1 | $0 |
| Investing Cash Flow | -$9 | $3 | $59 | -$41 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2 | $2 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$32 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $164 | $92 | $13 |
| Financing Cash Flow | $2 | $164 | $92 | $13 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$121 | $58 | $83 | -$65 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $170 | $112 | $29 | $94 |
| End Cash | $49 | $170 | $112 | $29 |
| Free Cash Flow | -$117 | -$114 | -$72 | -$37 |